Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | INBX |
---|---|---|
09:32 ET | 3059 | 14.5 |
09:34 ET | 200 | 14.55 |
09:38 ET | 378 | 14.0798 |
09:41 ET | 100 | 14.12 |
09:48 ET | 400 | 14.17 |
09:50 ET | 403 | 14.13 |
09:52 ET | 100 | 14.3 |
09:54 ET | 400 | 14.2 |
09:56 ET | 100 | 14.38 |
10:01 ET | 200 | 14.43 |
10:06 ET | 100 | 14.5 |
10:08 ET | 100 | 14.5 |
10:14 ET | 205 | 14.5 |
10:17 ET | 100 | 14.5 |
10:21 ET | 300 | 14.37 |
10:24 ET | 500 | 14.27 |
10:26 ET | 500 | 14.18 |
10:28 ET | 2971 | 14.17 |
10:30 ET | 300 | 14.15 |
10:32 ET | 700 | 14.15 |
10:33 ET | 500 | 14.155 |
10:35 ET | 544 | 14.21 |
10:37 ET | 200 | 14.24 |
10:39 ET | 700 | 14.265 |
10:44 ET | 200 | 14.265 |
10:48 ET | 100 | 14.29 |
10:50 ET | 100 | 14.265 |
10:57 ET | 300 | 14.285 |
11:00 ET | 3861 | 14.14 |
11:02 ET | 200 | 14.135 |
11:06 ET | 100 | 14.135 |
11:09 ET | 2000 | 14.22 |
11:11 ET | 300 | 14.14 |
11:13 ET | 700 | 14.19 |
11:15 ET | 500 | 14.105 |
11:18 ET | 400 | 14.04 |
11:20 ET | 1000 | 14.16 |
11:22 ET | 200 | 14.15 |
11:24 ET | 600 | 14.17 |
11:26 ET | 372 | 14.22 |
11:27 ET | 200 | 14.18 |
11:29 ET | 900 | 14.155 |
11:31 ET | 1504 | 14.15 |
11:33 ET | 300 | 14.155 |
11:36 ET | 700 | 14.22 |
11:40 ET | 200 | 14.15 |
11:42 ET | 300 | 14.21 |
11:44 ET | 496 | 14.13 |
11:45 ET | 822 | 14.1 |
11:47 ET | 500 | 14.075 |
11:49 ET | 663 | 13.96 |
11:51 ET | 100 | 14 |
11:54 ET | 552 | 13.995 |
11:56 ET | 1320 | 13.99 |
11:58 ET | 100 | 13.995 |
12:03 ET | 100 | 13.995 |
12:05 ET | 300 | 14.05 |
12:09 ET | 100 | 14.04 |
12:12 ET | 1100 | 14.17 |
12:14 ET | 400 | 14.205 |
12:18 ET | 200 | 14.19 |
12:21 ET | 300 | 14.14 |
12:27 ET | 650 | 14.13 |
12:41 ET | 200 | 14.17 |
12:43 ET | 175 | 14.2 |
12:48 ET | 500 | 14.2 |
12:52 ET | 300 | 14.17 |
12:57 ET | 200 | 14.17 |
01:03 ET | 200 | 14.12 |
01:08 ET | 100 | 14.15 |
01:10 ET | 100 | 14.11 |
01:12 ET | 200 | 14.1 |
01:15 ET | 100 | 14.11 |
01:17 ET | 100 | 14.09 |
01:19 ET | 300 | 14.075 |
01:21 ET | 450 | 14.045 |
01:24 ET | 400 | 13.995 |
01:26 ET | 200 | 13.92 |
01:28 ET | 300 | 13.91 |
01:30 ET | 2917 | 13.91 |
01:32 ET | 400 | 13.9 |
01:33 ET | 100 | 13.88 |
01:35 ET | 2273 | 13.77 |
01:37 ET | 1819 | 13.77 |
01:39 ET | 300 | 13.78 |
01:42 ET | 1749 | 13.88 |
01:44 ET | 740 | 13.8901 |
01:48 ET | 100 | 13.87 |
01:50 ET | 600 | 13.99 |
01:51 ET | 926 | 13.98 |
01:55 ET | 100 | 13.84 |
02:00 ET | 100 | 13.885 |
02:02 ET | 200 | 13.93 |
02:04 ET | 200 | 13.94 |
02:06 ET | 629 | 13.94 |
02:08 ET | 100 | 13.88 |
02:09 ET | 400 | 13.95 |
02:11 ET | 100 | 14.03 |
02:13 ET | 300 | 14.06 |
02:15 ET | 200 | 14.07 |
02:20 ET | 600 | 14.09 |
02:22 ET | 100 | 14.19 |
02:24 ET | 300 | 14.17 |
02:26 ET | 100 | 14.14 |
02:27 ET | 100 | 14.19 |
02:29 ET | 100 | 14.19 |
02:31 ET | 200 | 14.15 |
02:33 ET | 100 | 14.15 |
02:40 ET | 400 | 14.15 |
02:42 ET | 1120 | 14.155 |
02:44 ET | 496 | 14.045 |
02:51 ET | 300 | 14.09 |
02:56 ET | 394 | 14.15 |
02:58 ET | 100 | 14.15 |
03:00 ET | 100 | 14.16 |
03:02 ET | 100 | 14.15 |
03:03 ET | 200 | 14.14 |
03:05 ET | 400 | 14.16 |
03:07 ET | 300 | 14.14 |
03:09 ET | 100 | 14.14 |
03:12 ET | 317 | 14.115 |
03:14 ET | 3132 | 14.095 |
03:18 ET | 100 | 13.995 |
03:20 ET | 2200 | 13.985 |
03:21 ET | 610 | 14.02 |
03:23 ET | 300 | 14.03 |
03:25 ET | 900 | 14.05 |
03:27 ET | 400 | 14.14 |
03:30 ET | 400 | 14.16 |
03:32 ET | 525 | 14.11 |
03:34 ET | 941 | 14.09 |
03:38 ET | 500 | 14.11 |
03:39 ET | 100 | 14.13 |
03:41 ET | 7164 | 14.13 |
03:43 ET | 500 | 14.17 |
03:45 ET | 11061 | 14.15 |
03:48 ET | 3325 | 14.13 |
03:50 ET | 2380 | 14.16 |
03:52 ET | 45709 | 14.265 |
03:54 ET | 8455 | 14.37 |
03:56 ET | 25171 | 14.205 |
03:57 ET | 22676 | 14.12 |
03:59 ET | 12065 | 14.17 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Inhibrx Biosciences Inc | 205.1M | -2.6x | --- |
Century Therapeutics Inc | 212.1M | -1.1x | --- |
Inovio Pharmaceuticals Inc | 209.4M | -1.5x | --- |
Fractyl Health Inc | 204.5M | -2.5x | --- |
Gossamer Bio Inc | 203.8M | -0.9x | --- |
Q32 Bio Inc | 214.4M | -0.7x | --- |
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. The Company’s clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106. INBRX-109 is a tetravalent agonist of death receptor 5 (DR5) that is designed with its proprietary single domain antibody, or sdAb, platform to drive cancer-selective programmed cell death and to maximize potency while minimizing on-target liver toxicity arising from hepatocyte apoptosis. INBRX-106 is a hexavalent OX40 agonist, being investigated as a single agent and in combination with Keytruda, a PD-1 blocking checkpoint inhibitor, in patients with locally advanced or metastatic solid tumors. INBRX-106 is a precisely engineered hexavalent sdAb-based therapeutic candidate targeting OX40, designed to be an optimized agonist of this co-stimulatory receptor.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $205.1M |
---|---|
Revenue (TTM) | $1.8M |
Shares Outstanding | 14.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-5.35 |
Book Value | $0.92 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | 115.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -13,980.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.